Software-defined storage (SDS) is a key driver of data center transformation. As a data center grade SDS, the enterprise features, availability, performance and flexibility of ScaleIO make it perfect for traditional array consolidation, private cloud/IaaS, and new emerging technologies like DevOps and container microservices.Customers love that they can use industry-standard hardware, Ethernet and ScaleIO to reduce costs, simplify storage lifecycle management, and begin operating with ruthless efficiency.The first set of new features focuses on space efficiency, to provide more effective usable capacity and improve the total cost of ownership for our customers. ScaleIO.Next introduces multiple space efficiency features including inline compression, space- efficient thin provisioning and flash-based snapshots. In addition, snapshots get an additional boost in ScaleIO.Next by enabling the creation of more snapshot copies, automating snap management and adding unrestricted refresh / restore capabilities. This is huge for customers who want to shrink their storage footprint and reduce costs using software-defined storage.Since ScaleIO is hardware agnostic, it’s very easy for us to take advantage of new hardware releases immediately. Therefore, with ScaleIO.Next we will by providing performance and acceleration advancements using Dell PowerEdge 14G and NVMe Drives for the ScaleIO Ready Node. This will provide performance and metadata acceleration using NVDIMMs and NVMe drives to support the most-demanding customer applications in the data center.Additionally, ScaleIO.Next has a strong focus on simpler storage lifecycle management. This release enables even tighter integration with VMware environments with full vVols support, reducing overhead on the hypervisor, allowing administrators to consume data services at the VM granularity and offloading data services to ScaleIO.ScaleIO.Next also provides seamless volume migration which simplifies storage operations as ScaleIO now provides the flexibility to rearrange and optimize data placement on All-Flash, Hybrid or HDD-only media at any time. Customers can now easily balance performance and cost of data with these new abilities.ScaleIO also streamlines provisioning and management of ScaleIO Ready Nodes with new Automated Management Services (AMS) features. AMS provides complete lifecycle management of ScaleIO Ready Nodes: deploy ScaleIO, upgrade the OS / hypervisor, apply patches for firmware, and monitor the hardware components. The enhanced capabilities of AMS in ScaleIO.Next add support for storage nodes running on RHEL 6 & 7 and allow customers to deploy a traditional two tier ScaleIO configuration, where ScaleIO Ready Nodes can host either applications or storage.Last but certainly not least, ScaleIO.Next introduces a myriad of additional new features to improve reliability, availability, scalability and ease-of-use.As you can see, we’ve packed a lot into this release, designed to . deliver improved efficiency, performance, and management of SDS.
Delayed diagnosis, reliance on traditional and unproven medical techniques, and a serious lack of chronic disease management skills are causing India and several other South Asian countries to stay behind in diabetes treatment, according to a new study.In the latest edition of the popular medical journal, The Lancet Diabetes & Endocrinology, a group of seven doctors from India, Australia, and Britain said that with updated and improved diabetes management skills along with improvement in doctors’ skill, diabetes could be easily tackled in the region.The doctors wrote in the journal that preventing type 2 diabetes in South Asia is possible through “a combination of lifestyle changes and long-term health care management.” The study also delves into the serious challenges relating to diabetes care that many people in the region face due to inadequate resources. The doctors also focused on the effective primary prevention strategies that are urgently needed to counter risk factors and behaviors during pre-conception, in utero, in infancy, and during childhood and adolescence.According to the doctors, South Asian countries like Bangladesh, Bhutan, India, Nepal, Pakistan, and Sri Lanka need to focus more on education, training, and capacity building at the community level to ensure widespread use of non-physician care including community health workers. “Major investment from governments and other sources will be essential to achieve substantial improvements in the prevention and management of type 2 diabetes in the region,” the doctors wrote.Prof. Anoop Mishra, Director, Fortis Center for Diabetes, Obesity and Cholesterol, New Delhi and one of the authors of the study said, “Prevention and treatment of diabetes needs to be far more aggressive than it is now. Many patients are likely to develop complications only because of poor management.”Mishra told the Indian newspaper Telegraph that culturally appropriate lifestyle modification can help prevent and manage diabetes, especially in resource-poor settings of South Asian countries.Citing data from a study of diabetes patients in the National Capital Region of India, the study said that only 8% of people among a sample of 408 diabetes patients got a detailed eye examination and about 15% had received a foot examination in the last 12 months. “Periodic eye and foot examinations are crucial in detecting early signs of complications of diabetes. The stark difference in numbers portray the contradictory scenarios with high income countries, where almost 90% patients receive the required eye and foot examinations,” the study said.Another major obstacle in the treatment of diabetes in India and South Asia is the blind faith in traditional medical practices like Ayurveda, Yoga, Unani, Siddha, and Homoeopathy which have not proven to be completely effective in dealing with diabetes, the newspaper wrote quoting the study.“The problem magnifies mainly when we prescribe insulin to patients who need it,” the newspaper quoted Satinath Mukhopadhyay, a diabetologist at the Institute of Postgraduate Medical Education and Research, Calcutta as saying. “The fear of needles forces some of them to (take recourse to) alternative systems of medicines, and (their) blood sugar (level) goes for a toss.”Between 67-76% of diabetes patients are tempted to take alternative medication at some point, the publication said quoting earlier studies. Related Items